Richard Vosser

Analyst-Equity presso JPMorgan Securities Plc

Finance

Profilo

Richard Vosser is currently the Head of Pharmaceuticals & Biotechnology at JPMorgan Securities Plc.
Previously, he worked as a Research Analyst at Bear Stearns International Ltd.

Posizioni attive di Richard Vosser

Società	Posizione	Inizio
JPMorgan Securities Plc JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets.	Analyst-Equity	01/06/2008

Tutte le posizioni attive di Richard Vosser

Precedenti posizioni note di Richard Vosser

Società	Posizione	Fine
Bear Stearns International Ltd.	Analyst-Equity	-

Vedi nel dettaglio l'esperienza di Richard Vosser

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Richard Vosser

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Bear Stearns International Ltd.	Finance
JPMorgan Securities Plc JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets.	Finance